Phosphorous Compound Active Ingredients TRIZ Cases
- HSP70 Inhibitor Compounds for Immunogenic Tumor Cell Death
Targeting HSP70 in tumor and mitochondrial compartments drives immunogenic cell death, boosts immune infiltration, and limits tumor growth.
- Linear ALK Inhibitors for LTK-Positive Multiple Myeloma
Linear ALK inhibitors extend treatment to ALK-negative, LTK-positive myeloma by triggering ER stress and apoptosis in hypersecretory cells.
- BTN3A1/BTN2A1 Binding Modulators for Stable Vγ9Vδ2 T Cell Activation
Small molecules bridge BTN3A1 and BTN2A1 to activate Vγ9Vδ2 T cells while improving plasma stability and drugability.
- Antiviral JAK Inhibitor Combinations for HIV Reservoir and Resistance Control
This case combines JAK inhibitors with antiretrovirals to apply multiple mechanisms against HIV reservoirs and minimize virological failure.
- Phosphorus-Containing Compounds for Electrostatic TEAD Binding
This case uses phosphorus groups to bind electrostatic TEAD pockets while improving bioavailability and metabolic stability.
- Dual Cysteine Conjugation for Tunable ADC Drug Loading
This ADC process combines engineered and interchain cysteines to tune DAR, improve homogeneity, and reduce high-molecular-weight species.
- Anionic Lipid Surfactant for Lung Inflammation and RSV Inhibition
Anionic lipid surfactants inhibit LPS-induced inflammatory responses and suppress viral infections through receptor interactions.
- Pharmaceutical Formulation for Premature Ejaculation Treatment
Combining escitalopram with Rhizoma Corydalis extract delays ejaculation while reducing side effects associated with higher antidepressant dosages.
- Zoledronic Acid Disodium Salt Oral Bioavailability
Disodium salt form of zoledronic acid enables effective oral administration for treating bone-related conditions.
- TrkB Receptor Antagonists for Cognitive Flexibility
Selective TrkB receptor antagonists restore cognitive flexibility by blocking excessive BDNF signaling that impairs mental function in ADHD and schizophrenia.
- Zoledronic Acid Disodium Salt Bioavailability
Disodium salt form of zoledronic acid improves oral bioavailability, enabling lower doses to treat complex regional pain syndrome.
- Glutathione Inhibitor Combination Therapy for Melanoma Resistance
Pretreating with glutathione synthesis inhibitors depletes cellular redox reserves, preventing MAPK inhibitor resistance and extending durable tumor response.
- Formula I Anti-HPV Compounds for Recurrence Prevention
Formula I compounds inhibit viral activity and reduce recurrence while minimizing adverse effects during pregnancy.
- Glutathione Inhibitor Combination Therapy for Melanoma Drug Resistance
Combining glutathione synthesis inhibitors with MAPK inhibitors prevents rapid drug resistance development by targeting cellular redox equilibrium.
- Azabisphosphonate Dendrimer Vesicles for Deep Skin Penetration
Vesicles lower membrane transition temperature to improve deep skin penetration, reducing systemic side effects while treating psoriasis inflammation.
- Bisphosphonate Treatment for Heart Failure Cardiac Dysfunction
Bisphosphonates treat heart failure by increasing cardiac contractility and reducing inflammatory cytokines to lower mortality rates.
- Phosphatidic Acid and Magnesium Composition for Menopausal Symptom Relief
Replacing phosphatidyl-L-serine with phosphatidic acid combined with magnesium addresses limited treatment effectiveness for menopause discomfort.
- Zoledronic Acid Disodium Salt Oral Bioavailability
Converting zoledronic acid to disodium salt overcomes low oral bioavailability, providing sustained plasma levels and prolonged pain relief.
- Mitoquinone BPH Treatment Inhibiting AR and NLRP3 Pathways
Mitoquinone suppresses dihydrotestosterone-induced proliferation via AR and NLRP3 inhibition, resolving synthetic drug side effects.
- Mitochondria-Targeted Combination Therapy for Cancer
Gamitrinib combined with PI3K inhibitors reverses tumor reprogramming by disrupting mitochondrial bioenergetics, overcoming treatment resistance.
- Zoledronic Acid Disodium Salt for Oral Bioavailability
Disodium salt form of zoledronic acid overcomes low oral bioavailability of diacid forms, enabling effective pain relief with reduced dosage amounts.
- Osmolyte Nasal Sprays for Viral Respiratory Disease Treatment
Topical osmolytes stabilize cellular structures to prevent viral attachment, reducing side effects from conventional anti-inflammatory treatments.
- Phosphoramidate Peptidomimetic Inhibitors for PSMA Targeting
Phosphoramidate peptidomimetics target PSMA to overcome antibody limitations in vascular permeability and delivery efficiency.
- Miltefosine Treatment for Amoebic Infection Recurrence
Miltefosine combined with secondary agents treats resistant amoeba cysts, reducing infection recurrence.
- Nrf2 Agonist and Antiviral Combination for Viral Infection Treatment
Segments antiviral mechanisms using Nrf2 agonists and nucleosides to reduce resistance development against divergent strains.